Онлайн КрасотаКаталог

Брошюра «Клинические исследования пептидных биорегуляторов» Электронная версия на английском языке — страница 24

Книги и пособия · 125 страниц · 0.7 МБ · Полное издание

Читать текстСкачать PDF
Vladonix® and a decrease in the incidence of complications. It is noteworthy that the patients of the primary group tolerated radiation and chemotherapy more easily. All were able to complete the entire course of radiation therapy (in the control group - 79%). CONCLUSION Clinical trials have shown that VLADONIX® contributes to the normalization of cellular immunity indicators and stimulates tissue regeneration processes in the event of their suppression. It does not cause side effects, complications, or drug dependence. It can be used for therapeutic and prophylactic purposes in combination with any means of symptomatic and pathogenetic therapy used to correct secondary immunodeficiency states (immunomodulators, adaptogens, vitamins, etc.). VLADONIX® is recommended to be used to accelerate the restoration of the functions of the immune system after infectious diseases, radiation, and chemotherapy, exposure of the body to various extreme factors (including ionizing and microwave radiation). It is also recommended for the elderly to maintain the functions of the immune system. It is recommended to take VLADONIX® 10-15 minutes before meals, 1-3 capsules 2-3 times a day for 20-30 days. A second course is desirable in 3-6 months. There were no side effects, complications, contraindications, or drug dependence observed during the clinical study when using VLADONIX®. REFERENCES 1. Drannik G.N., Grinevich Y.A., Disik G.M. Immunotropic medication. – Kiev Zdorov’ya, 1994. – 288 p. 2. Mashkovsky M.D., Medicines: Pharmacotherapy for doctors, manual: 2 parts. – Vilnius: ZAO “Gamta”, 1993. 3. Novikov V.S., Smirnov V.S. Immune physiology of extreme conditions. – SPb.: Nauka, 1995. – 172 p. 4. Schek M.G., Kosinets A.N., Adamenko G.P. Immunological aspects of surgical infection. – Vitebsk: B. i., 1994. – 140 p. RECOMMENDATIONS FOR USE The drug contains a complex of peptide compounds isolated from the thymus of healthy calves aged between 6-12 months. The peptides included in VLADONIX® selectively act on the cells of the im- mune system, regulating its functions and normalizing cell metabolism. The drug will help comprehen- sively restore the immune system after past illnesses, after being exposed to extreme environmental factors, unbalanced nutrition, aging, and pathological conditions, as a result of which the functions of the immune system are impaired. Depending on the goals (prevention, treatment) and the severity of pathological manifestations, VLADONIX® is taken for 10-20 days. Adults: 1-2 capsules 1-2 times a day with meals. The duration of admission is 30 days. Do not use in case of: individual intolerance to the components, during pregnancy or breastfeeding. No side effects have been identified. It is recommended to repeat the course of treatment after 6 months. Store in a dry, dark place at a temperature of +2 to +25 oC. Release form: 20 or 60 capsules of 0.2 g. Shelf life: 5 years from the date of manufacture. Responsible executor: A.A. Veretenko Executor: O.U. Raigorodsky Deputy Director of the LLC «Medical Center Chief Physician of the LLC «Medical Center of of the St. Petersburg Institute of Bioregulation the St. Petersburg Institute of Bioregulation and and Gerontology, SZO RAMS» for clinical work, Gerontology, SZO RAMS», Candidate of Medical Candidate of Medical Sciences (PhD in Medical Sciences (PhD in Medical Science) Science), Associate Professor

Для таблиц, дозировок и примечаний сверяйтесь с оригинальным PDF: при извлечении текста порядок колонок может измениться.

Из библиотеки Peptides. Авторство и содержание оригинала сохранены. Размещено с разрешения поставщика.